Introducing SoundCell’s cutting-edge susceptibility testing platform: the MelodyOne. Much faster than traditional methods, it uses graphene-based biosensors to measure bacterial nanomotion on a single cell level, in real time, revealing if antibiotics are working.
Making an impact where it matters most.
SoundCell is on a mission to give patients with severe infections a fighting chance against antibiotic resistance, now and in the future.
We make ideas become reality. From prototypes to polished solutions, our team and experts makes it happen. We’re a fast-growing startup with big ambitions, and we’re looking for creative, driven talent like you to help shape what’s next.
This project is funded by the European Commission under
grant agreement no. 10113671.
